As one of the earliest and largest investors in Gavi, the Vaccine Alliance, the United States government (USG) is a critical partner in Gavi's mission to increase access to lifesaving vaccines.

PATH is working closely with our partners to advocate for increased investment from the USG, ahead of Gavi's next replenishment cycle for 2026-2030.

We designed this community factsheet on Gavi's impact for use by advocates to support their engagements with Congress.